venBio Partners

HQ · California

Life-sciences venture investing in biopharmaceutical companies developing treatments for unmet medical needs, including academic startups and spinouts. The firm invests from early through late stages, leads most investments, builds syndicates, and supports companies through clinical development and commercialization.

Stage focus

SeedSeries ASeries B

Lead / follow

Mostly Lead

Specialization

Life SciencesDeep Tech

Generalist / Specialist

Specialist

Latest fund size

$528M — venBio Global Strategic Fund V

Latest fund vintage

2024

Investing team

Corey Goodman, PhDCo-founder & Managing Partner
Aaron Royston, MD, MBAManaging Partner
Richard Gaster, MD, PhDManaging Partner
Yvonne Yamanaka, PhDPartner
Parthiv PatelAnalyst

How to reach them

info@venbio.com

Notable investments

April 16, 2026: venBio Partners was named a new investor leading Achieve Life Sciences’ private placement.

Sources

venbio.com/firm ↗venbio.com/achieve-life-sciences-announces-up-to-354-million-private-placement ↗venbio.com/venbio-raises-528-million-venture-capital-fund-focused-on-life-sciencecompanies ↗venbio.com/team ↗venbio.com/team/aaron-royston ↗venbio.com/team/richard-gaster ↗venbio.com/team/corey-goodman ↗venbio.com/team/yvonne-yamanaka ↗venbio.com/team/parthiv-patel ↗adviserinfo.sec.gov/firm/summary/290045 ↗venbio.com ↗sec.gov/Archives/edgar/data/1776382/000090514825000652/0000905148-25-000652-index.htm ↗venbio.com/press/9 ↗